Paper2425441
Transfer factor and other T cell products.
Tsang KY and 1 other. Springer Semin Immunopathol, 1986. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Transfer factor and other T cell products. Papers, record 2425441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2425441
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphokines | Major topic |
| RNA | Major topic |
| Transfer Factor | Major topic |
| Acquired Immunodeficiency Syndrome | |
| Animals | |
| Antigens, Neoplasm | |
| Cell Extracts | |
| Cricetinae | |
| Cytotoxicity, Immunologic | |
| Fibrosarcoma | |
| Humans | |
| Hypersensitivity, Delayed | |
| Immunity, Cellular | |
| Interleukin-2 | |
| Kidney Neoplasms | |
| Lymphocytes | |
| Melanoma | |
| Osteosarcoma | |
| Rabbits |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,676,186 | The cell-migration-inhibition correlate of delayed hypersensitivity. Conversion of human nonsensitive lymph node cells to sensitive cells with an RNA extract. | J Immunol | 1968 | https://conductscience.org/library/papers/5676186 | PubMed |
| 2 | 6,180,855 | Transfer of cellular immunity in vivo with immune RNA in an allogeneic murine model. | Clin Immunol Immunopathol | 1982 | https://conductscience.org/library/papers/6180855 | PubMed |
| 3 | 1,277,593 | Preliminary studies on human "transfer factor" activity in guinea pigs. Systemic transfer of cutaneous delayed-type hypersensitivity to PPD and SKSD. | Clin Immunol Immunopathol | 1976 | https://conductscience.org/library/papers/1277593 | PubMed |
| 4 | 304,487 | Lymphocyte populations participating in cellular antitumor immune responses mediated by immune RNA. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/304487 | PubMed |
| 5 | 5,379,081 | Protection of C3H mice against BP8 tumour by RNA extracted from lymph-nodes and spleens of specifically sensitized mice. Preliminary communication. | Acta Pathol Microbiol Scand | 1969 | https://conductscience.org/library/papers/5379081 | PubMed |
| 6 | 7,049,471 | Treatment of Mycobacterium fortuitum pulmonary infection with "transfer factor" (TF): new methodology for evaluating TF potency and predicting clinical response. | Clin Immunol Immunopathol | 1982 | https://conductscience.org/library/papers/7049471 | PubMed |
| 7 | 89,691 | Idiotypic determinants in alloantigen receptors. I. Role in a leucocyte migration inhibition reaction. | Scand J Immunol | 1979 | https://conductscience.org/library/papers/89691 | PubMed |
| 8 | 466,714 | A comparative study of RNA fractions mediating delayed sensitivity to a chemically defined antigen in vitro. | Cell Immunol | 1979 | https://conductscience.org/library/papers/466714 | PubMed |
| 9 | 1,277,305 | Evidence that immune RNA is messenger RNA. | Cell Immunol | 1976 | https://conductscience.org/library/papers/1277305 | PubMed |
| 10 | 908,623 | Tuberculin-specific transfer factor in dogs. | Infect Immun | 1977 | https://conductscience.org/library/papers/908623 | PubMed |
| 11 | 6,193,434 | In vitro induction of chronic myeloid leukemia associated immune reactivity in normal human lymphocytes by xenogeneic immune RNA. | Neoplasma | 1983 | https://conductscience.org/library/papers/6193434 | PubMed |
| 12 | 6,361,122 | Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates. | J Immunol | 1984 | https://conductscience.org/library/papers/6361122 | PubMed |
| 13 | 1,111,976 | Transfer factor--transfer of tuberculin cutaneous sensitivity in an allogeneic and xenogeneic monkey model. | Cell Immunol | 1975 | https://conductscience.org/library/papers/1111976 | PubMed |
| 14 | 618,691 | Kinetics of the transfer of tumor-specific cytotoxicity with immune RNA. | Clin Immunol Immunopathol | 1978 | https://conductscience.org/library/papers/618691 | PubMed |
| 15 | 699,059 | Identification of the principal cell type yielding immune RNA capable of transferring tumor-specific cellular cytotoxicity. | Cell Immunol | 1978 | https://conductscience.org/library/papers/699059 | PubMed |
| 16 | 6,188,924 | Immune RNA therapy as an effective adjuvant immunotherapy after surgery: an animal model. | J Surg Oncol | 1983 | https://conductscience.org/library/papers/6188924 | PubMed |
| 17 | 3,883,363 | "Transfer factor": an update. | Proc Soc Exp Biol Med | 1985 | https://conductscience.org/library/papers/3883363 | PubMed |
| 19 | 5,125,669 | RNA-mediated transfer of tumor immunity--a new model for the immunotherapy of cancer. | Cancer | 1971 | https://conductscience.org/library/papers/5125669 | PubMed |
| 20 | 6,164,471 | Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma. | Cancer | 1981 | https://conductscience.org/library/papers/6164471 | PubMed |
| 21 | 14,223,928 | TRANSFER OF HEIGHTENED IMMUNITY TO SKIN HOMOGRAFTS BY LYMPHOID RNA. | J Clin Invest | 1964 | https://conductscience.org/library/papers/14223928 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2425441
GET https://conductscience.org/api/papers/v1/2425441/references?page=2